mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.09 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.09 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.09 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.09 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.09 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |